• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳青霉烯类耐药肠杆菌科细菌定植的危重症患者的肠道微生物群改变:一项临床分析。

Gut microbiota alterations in critically Ill patients with carbapenem-resistant Enterobacteriaceae colonization: A clinical analysis.

作者信息

Baek Moon Seong, Kim Seungil, Kim Won-Young, Kweon Mi-Na, Huh Jin Won

机构信息

Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea.

Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

出版信息

Front Microbiol. 2023 Apr 4;14:1140402. doi: 10.3389/fmicb.2023.1140402. eCollection 2023.

DOI:10.3389/fmicb.2023.1140402
PMID:37082174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10110853/
Abstract

BACKGROUND

Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging concern for global health and are associated with high morbidity and mortality in critically ill patients. Risk factors for CRE acquisition include broad-spectrum antibiotic use and microbiota dysbiosis in critically ill patients. Therefore, we evaluated the alteration of the intestinal microbiota associated with CRE colonization in critically ill patients.

METHODS

Fecal samples of 41 patients who were diagnosed with septic shock or respiratory failure were collected after their admission to the intensive care unit (ICU). The gut microbiota profile determined using 16S rRNA gene sequencing and quantitative measurement of fecal short-chain fatty acids were evaluated in CRE-positive ( = 9) and CRE negative ( = 32) patients. The analysis of bacterial metabolic abundance to identify an association between CRE acquisition and metabolic pathway was performed.

RESULTS

CRE carriers showed a significantly increased proportion of the phyla Proteobacteria and decreased numbers of the phyla Bacteroidetes as compared to the CRE non-carriers. Linear discriminant analysis (LDA) with linear discriminant effect size showed that the genera , , , , , , and had an upper 2 LDA score in CRE carriers. The alpha-diversity indices were significantly decreased in CRE carriers, and beta-diversity analysis demonstrated that the two groups were clustered significantly apart. Among short-chain fatty acids, the levels of isobutyric acid and valeric acid were significantly decreased in CRE carriers. Furthermore, the PICRUSt-predicted metabolic pathways revealed significant differences in five features, including ATP-binding cassette transporters, phosphotransferase systems, sphingolipid metabolism, other glycan degradation, and microbial metabolism, in diverse environments between the two groups.

CONCLUSION

Critically ill patients with CRE have a distinctive gut microbiota composition and community structure, altered short-chain fatty acid production and changes in the metabolic pathways. Further studies are needed to determine whether amino acids supplementation improves microbiota dysbiosis in patients with CRE.

摘要

背景

耐碳青霉烯类肠杆菌科细菌(CRE)是全球卫生领域新出现的一个问题,与重症患者的高发病率和高死亡率相关。获得CRE的风险因素包括重症患者使用广谱抗生素和微生物群失调。因此,我们评估了重症患者中与CRE定植相关的肠道微生物群的改变。

方法

对41例诊断为感染性休克或呼吸衰竭的患者在入住重症监护病房(ICU)后采集粪便样本。在CRE阳性(n = 9)和CRE阴性(n = 32)患者中,评估了使用16S rRNA基因测序确定的肠道微生物群谱以及粪便短链脂肪酸的定量测量。进行细菌代谢丰度分析以确定CRE获得与代谢途径之间的关联。

结果

与非CRE携带者相比,CRE携带者中变形菌门的比例显著增加,拟杆菌门的数量减少。具有线性判别效应大小的线性判别分析(LDA)表明,在CRE携带者中,[具体菌属]的LDA得分高于2。CRE携带者的α多样性指数显著降低,β多样性分析表明两组明显聚类分开。在短链脂肪酸中,CRE携带者中异丁酸和戊酸的水平显著降低。此外,PICRUSt预测的代谢途径显示,两组在不同环境中的五个特征存在显著差异,包括ATP结合盒转运蛋白、磷酸转移酶系统、鞘脂代谢、其他聚糖降解和微生物代谢。

结论

患有CRE的重症患者具有独特的肠道微生物群组成和群落结构,短链脂肪酸产生改变以及代谢途径变化。需要进一步研究以确定补充氨基酸是否能改善CRE患者的微生物群失调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f52/10110853/d39eed938d0c/fmicb-14-1140402-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f52/10110853/9ba2e2caab11/fmicb-14-1140402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f52/10110853/94f1a75d84b8/fmicb-14-1140402-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f52/10110853/d39eed938d0c/fmicb-14-1140402-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f52/10110853/9ba2e2caab11/fmicb-14-1140402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f52/10110853/94f1a75d84b8/fmicb-14-1140402-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f52/10110853/d39eed938d0c/fmicb-14-1140402-g003.jpg

相似文献

1
Gut microbiota alterations in critically Ill patients with carbapenem-resistant Enterobacteriaceae colonization: A clinical analysis.碳青霉烯类耐药肠杆菌科细菌定植的危重症患者的肠道微生物群改变:一项临床分析。
Front Microbiol. 2023 Apr 4;14:1140402. doi: 10.3389/fmicb.2023.1140402. eCollection 2023.
2
Intestinal Dysbiosis in Carriers of Carbapenem-Resistant .携带碳青霉烯类耐药菌的肠道菌群失调
mSphere. 2020 Apr 29;5(2):e00173-20. doi: 10.1128/mSphere.00173-20.
3
Alteration of Gut Microbiota in Carbapenem-Resistant Enterobacteriaceae Carriers during Fecal Microbiota Transplantation According to Decolonization Periods.根据去定植时期,粪便微生物群移植期间耐碳青霉烯类肠杆菌科细菌携带者肠道微生物群的变化
Microorganisms. 2021 Feb 10;9(2):352. doi: 10.3390/microorganisms9020352.
4
Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.基于粪便代谢组学联合 16S rRNA 基因测序分析肾阳虚证大鼠肠道菌群变化及右归丸的干预作用
J Ethnopharmacol. 2019 Nov 15;244:112139. doi: 10.1016/j.jep.2019.112139. Epub 2019 Aug 8.
5
Profile of the Gut Microbiome Containing Carbapenem-Resistant Enterobacteriaceae in ICU Patients.重症监护病房患者中含有耐碳青霉烯类肠杆菌科细菌的肠道微生物群概况
Microorganisms. 2022 Jun 28;10(7):1309. doi: 10.3390/microorganisms10071309.
6
Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.重症患者中耐碳青霉烯类肠杆菌科细菌的定植与感染:与非携带者的回顾性匹配队列比较
J Hosp Infect. 2016 Sep;94(1):54-9. doi: 10.1016/j.jhin.2016.05.018. Epub 2016 Jun 6.
7
Characterization of the oral and gut microbiome in children with obesity aged 3 to 5 years.3 至 5 岁肥胖儿童口腔和肠道微生物组的特征。
Front Cell Infect Microbiol. 2023 Mar 29;13:1102650. doi: 10.3389/fcimb.2023.1102650. eCollection 2023.
8
[Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].[16S核糖体RNA高通量测序技术分析特重度烧伤患者肠道微生物群的动态变化]
Zhonghua Shao Shang Za Zhi. 2020 Dec 20;36(12):1159-1166. doi: 10.3760/cma.j.cn501120-20200518-00271.
9
Gut Dysbiosis Associated with Antibiotics and Disease Severity and Its Relation to Mortality in Critically Ill Patients.肠道菌群失调与抗生素使用、疾病严重程度及其与危重症患者死亡率的关系。
Dig Dis Sci. 2022 Jun;67(6):2420-2432. doi: 10.1007/s10620-021-07000-7. Epub 2021 May 3.
10
Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.异基因造血干细胞移植受者中针对碳青霉烯类耐药肠杆菌科定植的串联粪便微生物移植周期:一例病例报告及文献复习。
Eur J Med Res. 2021 Apr 28;26(1):37. doi: 10.1186/s40001-021-00508-8.

引用本文的文献

1
The deficiency of chymase mast cell protease 4 exacerbates dextran sulfate sodium salt-induced colitis in mice and is associated with altered microbiota and metabolome profiles.糜酶肥大细胞蛋白酶4缺乏会加重葡聚糖硫酸钠诱导的小鼠结肠炎,并与微生物群和代谢组谱的改变有关。
Front Cell Infect Microbiol. 2025 Jul 8;15:1481927. doi: 10.3389/fcimb.2025.1481927. eCollection 2025.
2
Challenges of Carbapenem-Resistant in the Development of New β-Lactamase Inhibitors and Antibiotics.耐碳青霉烯类在新型β-内酰胺酶抑制剂和抗生素研发中的挑战
Antibiotics (Basel). 2025 Jun 7;14(6):587. doi: 10.3390/antibiotics14060587.
3
Harnessing the human gut microbiota: an emerging frontier in combatting multidrug-resistant bacteria.

本文引用的文献

1
Profile of the Gut Microbiome Containing Carbapenem-Resistant Enterobacteriaceae in ICU Patients.重症监护病房患者中含有耐碳青霉烯类肠杆菌科细菌的肠道微生物群概况
Microorganisms. 2022 Jun 28;10(7):1309. doi: 10.3390/microorganisms10071309.
2
Economic impact of an outbreak of carbapenemase producing-Enterobacteriaceae in a surgical intensive care unit.产碳青霉烯酶肠杆菌科在外科重症监护病房爆发的经济影响。
Anaesth Crit Care Pain Med. 2022 Aug;41(4):101093. doi: 10.1016/j.accpm.2022.101093. Epub 2022 Apr 30.
3
Changes in the gut microbiota and risk of colonization by multidrug-resistant bacteria, infection, and death in critical care patients.
利用人类肠道微生物群:对抗多重耐药细菌的新前沿。
Front Immunol. 2025 Mar 17;16:1563450. doi: 10.3389/fimmu.2025.1563450. eCollection 2025.
4
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome.粪便(或肠道)微生物群移植:修复肠道微生物组的工具。
Gut Microbes. 2024 Jan-Dec;16(1):2423026. doi: 10.1080/19490976.2024.2423026. Epub 2024 Nov 5.
5
The Roles of a Multidrug-Resistant High-Risk Clone and Its Resistance Plasmids on the Gastrointestinal Colonization and Host-Defense Effectors in the Gut.多重耐药高危克隆及其耐药质粒在肠道定植和肠道宿主防御效应器中的作用
Antibiotics (Basel). 2024 Jul 26;13(8):698. doi: 10.3390/antibiotics13080698.
重症监护患者肠道微生物群的变化与多重耐药菌定植、感染和死亡的风险。
Clin Microbiol Infect. 2022 Jul;28(7):975-982. doi: 10.1016/j.cmi.2022.01.004. Epub 2022 Jan 20.
4
The role of the microbiota in the management of intensive care patients.微生物群在重症监护患者管理中的作用。
Ann Intensive Care. 2022 Jan 5;12(1):3. doi: 10.1186/s13613-021-00976-5.
5
Identification and infection control of carbapenem-resistant Enterobacterales in intensive care units.重症监护病房中耐碳青霉烯类肠杆菌科细菌的鉴定与感染控制
Acute Crit Care. 2021 Aug;36(3):175-184. doi: 10.4266/acc.2021.00409. Epub 2021 Aug 12.
6
A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis.全面综述:神经酰胺代谢与神经酰胺动态平衡破坏的影响。
Int J Mol Sci. 2021 May 28;22(11):5793. doi: 10.3390/ijms22115793.
7
Alteration of Gut Microbiota in Carbapenem-Resistant Enterobacteriaceae Carriers during Fecal Microbiota Transplantation According to Decolonization Periods.根据去定植时期,粪便微生物群移植期间耐碳青霉烯类肠杆菌科细菌携带者肠道微生物群的变化
Microorganisms. 2021 Feb 10;9(2):352. doi: 10.3390/microorganisms9020352.
8
Emerging superbugs: The threat of Carbapenem Resistant Enterobacteriaceae.新兴超级细菌:耐碳青霉烯类肠杆菌科细菌的威胁
AIMS Microbiol. 2020 Jul 1;6(3):176-182. doi: 10.3934/microbiol.2020012. eCollection 2020.
9
Update of the treatment of nosocomial pneumonia in the ICU.更新 ICU 中院内获得性肺炎的治疗方法。
Crit Care. 2020 Jun 29;24(1):383. doi: 10.1186/s13054-020-03091-2.
10
The Genus : Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health.属:具有潜在炎症、癌症和精神健康影响的肠道细菌。
Front Immunol. 2020 Jun 9;11:906. doi: 10.3389/fimmu.2020.00906. eCollection 2020.